Global Bio-chem Technology Group (00809) Releases November 2025 Monthly Return

Like
Comment
Favorite

Global Bio-chem Technology Group (00809) Releases November 2025 Monthly Return

Bulletin Express2025-12-01

Global Bio-chem Technology Group (00809) submitted its monthly return for the period ended 30 November 2025, confirming no changes to its overall share structure compared to the previous month. The total authorized share capital remains HKD 6,000,000,000, equally divided between ordinary shares and convertible preference shares at a par value of HKD 0.1 each.

As of 30 November 2025, the number of issued ordinary shares stood at 16,832,771,527, of which 44,560,000 were held as treasury shares. The remaining 16,788,211,527 ordinary shares were in issuance. The number of issued preference shares was 17,267,750,569, with an aggregate convertible amount of HKD 1,726,775,056.9. The conversion price is HKD 0.1, and these convertibles carry the potential to be transformed into ordinary shares.

The submission date for the filing was 01 December 2025, adhering to the applicable listing rules and relevant legal requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1179813072?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179813072","market":"hk","top_or_hot":-1,"title":"Global Bio-chem Technology Group (00809) Releases November 2025 Monthly Return","media":"Bulletin Express","content":"<p>Global Bio-chem Technology Group (00809) submitted its monthly return for the period ended 30 November 2025, confirming no changes to its overall share structure compared to the previous month. The total authorized share capital remains HKD 6,000,000,000, equally divided between ordinary shares and convertible preference shares at a par value of HKD 0.1 each.</p>\n<p>As of 30 November 2025, the number of issued ordinary shares stood at 16,832,771,527, of which 44,560,000 were held as treasury shares. The remaining 16,788,211,527 ordinary shares were in issuance. The number of issued preference shares was 17,267,750,569, with an aggregate convertible amount of HKD 1,726,775,056.9. The conversion price is HKD 0.1, and these convertibles carry the potential to be transformed into ordinary shares.</p>\n<p>The submission date for the filing was 01 December 2025, adhering to the applicable listing rules and relevant legal requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Global Bio-chem Technology Group (00809) Releases November 2025 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlobal Bio-chem Technology Group (00809) Releases November 2025 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-01 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Global Bio-chem Technology Group (00809) submitted its monthly return for the period ended 30 November 2025, confirming no changes to its overall share structure compared to the previous month. The total authorized share capital remains HKD 6,000,000,000, equally divided between ordinary shares and convertible preference shares at a par value of HKD 0.1 each.</p>\n<p>As of 30 November 2025, the number of issued ordinary shares stood at 16,832,771,527, of which 44,560,000 were held as treasury shares. The remaining 16,788,211,527 ordinary shares were in issuance. The number of issued preference shares was 17,267,750,569, with an aggregate convertible amount of HKD 1,726,775,056.9. The conversion price is HKD 0.1, and these convertibles carry the potential to be transformed into ordinary shares.</p>\n<p>The submission date for the filing was 01 December 2025, adhering to the applicable listing rules and relevant legal requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00809","symbol_name":"大成生化科技","start_time":0,"source_url":"","article_id":"1179813072","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179813072","pubTimestamp":1764579959,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Global Bio-chem Technology Group (00809) submitted its monthly return for the period ended 30 November 2025, confirming no changes to its overall share structure compared to the previous month. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00809":"大成生化科技"},"translate_title":"环球生化科技集团(00809)发布2025年11月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00809":1},"content_text":"Global Bio-chem Technology Group (00809) submitted its monthly return for the period ended 30 November 2025, confirming no changes to its overall share structure compared to the previous month. The total authorized share capital remains HKD 6,000,000,000, equally divided between ordinary shares and convertible preference shares at a par value of HKD 0.1 each.\nAs of 30 November 2025, the number of issued ordinary shares stood at 16,832,771,527, of which 44,560,000 were held as treasury shares. The remaining 16,788,211,527 ordinary shares were in issuance. The number of issued preference shares was 17,267,750,569, with an aggregate convertible amount of HKD 1,726,775,056.9. The conversion price is HKD 0.1, and these convertibles carry the potential to be transformed into ordinary shares.\nThe submission date for the filing was 01 December 2025, adhering to the applicable listing rules and relevant legal requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}